GlassScriptPhysician profile
Ranjiv Choudhary
NPI 1790746014
$6,650.15
in general payments reported to CMS, 2019-2025
38 companies · $1,069 in 2025
The $1,069 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2020: $480 · 2021: $566 · 2022: $857 · 2023: $778 · 2024: $785 · 2025: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,632.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,593.07 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $571.95 | 2019-2025 | Farxiga, Wainua, Andexxa |
| Boston Scientific Corporation | $516.89 | 2020-2025 | Rotapro, Versacross Access Solution, Avvigo Guidance System |
| Pfizer INC. | $484.99 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $405.88 | 2019-2025 | Verquvo, Belsomra |
| Amgen INC. | $366.25 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $323.97 | 2019-2025 | |
| Shockwave Medical, INC | $267.41 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $266.89 | 2019-2025 | Gallant, Pressurewire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $262.59 | 2019-2023 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $164.13 | 2019-2022 | |
| Medtronic, INC. | $157.42 | 2024 | Azure Xt Dr Mri Surescan, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $151.16 | 2019-2024 | Xarelto |
| Esperion Therapeutics, INC. | $138.48 | 2020-2023 | Nexletol |
| Biosense Webster, INC. | $119.00 | 2025 | Nuvision Ice Catheter |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $96.53 | 2025 | Flowtriever, Clottriever Bold Catheter, Triever20 |
| Alnylam Pharmaceuticals INC. | $75.03 | 2019-2023 | Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $67.36 | 2024-2025 | |
| Novo Nordisk INC | $52.05 | 2022-2023 | |
| Biotronik INC. | $50.08 | 2020-2025 | Orsiro Mission |
| Scpharmaceuticals INC. | $49.40 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $47.68 | 2022-2025 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $44.68 | 2023-2024 | Inpefa |
| Aegerion Pharmaceuticals, INC. | $42.27 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $37.16 | 2024 | Opsumit, Uptravi |
| Eisai INC. | $37.14 | 2021 | |
| Inari Medical, INC. | $35.63 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $28.08 | 2019-2020 | |
| Abbvie INC. | $23.60 | 2021 | |
| Lundbeck LLC | $23.53 | 2020 | |
| Radius Health, INC. | $21.80 | 2020 | |
| Lilly USA, LLC | $21.66 | 2025 | Zepbound, Mounjaro |
| Convatec INC. | $20.66 | 2025 | |
| Vifor Pharma, INC. | $19.79 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $18.79 | 2023 | Arcalyst |
| Abiomed | $18.71 | 2024 | Impella |
| Heartflow, INC. | $15.39 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjiv Choudhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.